| European Case Law Identifier: | ECLI:EP:BA:2002:T103800.20020326 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 26 March 2002 | ||||||||
| Case number: | T 1038/00 | ||||||||
| Application number: | 95913946.0 | ||||||||
| IPC class: | G01N 33/569 | ||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | C | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | A method for detecting and/or quantifying and/or separating apoptotic cells in or from a sample | ||||||||
| Applicant name: | NEXINS RESEARCH B.V. | ||||||||
| Opponent name: | (01) Boehringer Ingelheim GmbH (02) Miltenyi Biotec GmbH (03) Roche Diagnostics GmbH |
||||||||
| Board: | 3.3.04 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Intervention admissible (no) Inventive step (no) Admissibility of late filed set of claims (no) |
||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t001038eu1.html
Date retrieved: 17 May 2021